CANGRELOR WITH AND WITHOUT GLYCOPROTEIN IIB/IIIA INHIBITORS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
J Am Coll Cardiol. 2017;69(2):176-185. DOI: 10.1016/j.jacc.2016.10.055.
Leia mais
Publicações de Deepak Bhatt [3]
THREE VS TWELVE MONTHS OF DUAL ANTIPLATELET THERAPY AFTER ZOTAROLIMUS-ELUTING STENTS: THE OPTIMIZE RANDOMIZED TRIAL
Jama, 2013;310(23): 2510-22 – ISSN: 2086-7603 DOI: 10.1001/jama.2013.282183
Leia maisIMPACT OF SHORT- VERSUS LONG-TERM DAPT IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PERCUTANEOUS INTERVENTION WITH ENDEAVOR ZOTAROLIMUS-ELUTING STENTS – A SUBANALYSIS OF THE LARGE, PROSPECTIVE, RANDOMIZED, MULTICENTER OPTIMIZE TRIAL
Journal of the American College of Cardiology, 2014;(63):A1859-462 – ISSN: 0735-1097 DOI: 10.1016/S0735-1097(14)61862-3
Leia mais